Biotech and Pharmaceuticals
Eli Lilly sues four telehealth sites selling compounded Zepbound, Mounjaro
An injection pen of Zepbound, Eli Lilly’s weight loss drug, is displayed in New York City on Dec. 11, 2023. Brendan McDermid | Reuters Eli Lilly is suing four telehealth companies selling compounded versions of the pharmaceutical giant’s weight loss drug Zepbound and its diabetes treatment Mounjaro, the company’s latest attempt to crack down on […]
Read More
FDA to phase out dyes used in Flamin’ Hot Cheetos, Skittles and other snacks
Candy is displayed for sale, as U.S. Health and Human Services (HHS) Secretary Robert F. Kennedy, Jr., along with FDA Commissioner Marty Makary, announce the FDA’s intent to remove from the U.S. food supply “petroleum-based synthetic” food dyes, which are present in numerous foods such as breakfast cereals, candy, snacks, and beverages, at a grocery […]
Read More
Healthy Returns: Trump seeks to change Medicare drug price negotiations in a win for pharma
U.S. President Donald Trump speaks to the media during the annual White House Easter Egg Roll, on the South Lawn of the White House in Washington, D.C., U.S., April 21, 2025. Leah Millis | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to […]
Read More
Roche to invest $50 billion in the U.S. as pharma tariff threat lingers
A photo showing the logo of Swiss pharmaceutical giant Roche in Basel. SEBASTIEN BOZON | AFP | Getty Images Swiss pharmaceutical giant Roche on Tuesday said that it would invest $50 billion in the U.S. over the next five years, amid concerns about the impact of possible new White House tariffs on pharma goods from […]
Read More
UnitedHealth’s stock is plunging on higher medical costs. That may mean trouble for more insurers
The logo of UnitedHealth appears on the side of one of its office buildings in Santa Ana, California, on April 13, 2020. Mike Blake | Reuters UnitedHealth Group‘s stock sank 20% on Thursday after the company slashed its annual profit forecast, citing higher-than-expected medical costs in its privately run Medicare plans. Those bleak results from […]
Read More
Eli Lilly’s weight loss pill succeeds in first late-stage trial on diabetes patients
Eli Lilly on Thursday said its daily obesity pill met the company’s goals in the first of several late-stage trials, helping Type 2 diabetes patients lower their blood sugar and body weight and showing safety on par with popular injections on the market. The trial results are among the pharmaceutical industry’s most closely watched studies […]
Read More
Healthy Returns: What drugmakers are saying about Trump’s looming pharmaceutical tariffs
A worker is working on a drug production line at the production workshop of a pharmaceutical company in Meishan, China, on January 30, 2024. Nurphoto | Nurphoto | Getty Images A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to […]
Read More
Pfizer scraps daily weight loss pill after liver injury in one patient
Nikos Pekiaridis | Lightrocket | Getty Images Pfizer on Monday said it would end development of its experimental daily weight loss pill after a patient experienced a liver injury that was potentially caused by the drug in a trial. The patient did not experience any liver-related symptoms or side effects, a Pfizer spokesperson said in […]
Read More
Trump’s pharmaceutical tariffs could raise costs for patients, worsen drug shortages
A pharmacist collects medications for prescriptions at a pharmacy. Simon Dawson | Bloomberg | Getty Images President Donald Trump’s planned tariffs on pharmaceuticals imported into the U.S. could have wide-ranging consequences for drugmakers and American patients, some experts told CNBC. The duties could disrupt the complex pharmaceutical supply chain, drive up the prices of drugs […]
Read More
Healthy Returns: Trump says major pharmaceutical tariffs coming ‘very shortly’
U.S. President Donald Trump speaks, on the day he signs energy-related executive orders at the White House in Washington, D.C., U.S., April 8, 2025. Leah Millis | Reuters A version of this article first appeared in CNBC’s Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future […]
Read More